RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
04 déc. 2023 14h45 HE
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. APPOINTS
DESSY BONEVA, MD, FACS TO THE BOARD OF DIRECTORS Dr. Boneva is an experienced surgeon skilled in trauma, surgical
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
01 déc. 2023 12h32 HE
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. ANNOUNCES HIRING OF INTERIM CFO
Virender Ahluwalia will serve as Interim Chief Financial Officer
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board
28 nov. 2023 16h01 HE
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. APPOINTS STEPHEN TANNENBAUM
TO THE COMPANY'S BUSINESS ADVISORY BOARD. RetinalGeniX is an ophthalmic R&D company
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
09 nov. 2023 12h58 HE
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Announces Therapeutic Solutions Being Developed for Dry Age-Related Macular Degeneration
and Alzheimer’s Syndrome.
Dry Age-Related Macular Degeneration Market Size is projected to reach USD 3.19 billion by 2031, growing at a CAGR of 8.06%: Straits Research
01 août 2023 11h14 HE
|
Straits Research
New York, United States, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Age-related macular degeneration (AMD) disease causes the small central retinal macula of the eye to deteriorate. A crucial retina...
Macular Degeneration Treatment Market Size is projected to reach USD 15.16 billion by 2030, growing at a CAGR of 7.06%: Straits Research
19 juin 2023 09h20 HE
|
Straits Research
New York, United States, June 19, 2023 (GLOBE NEWSWIRE) -- The eye’s macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of central vision...